Strewler G J, Wronski T J, Halloran B P, Miller S C, Leung S C, Williams R D, Nissenson R A
Endocrinology. 1986 Jul;119(1):303-10. doi: 10.1210/endo-119-1-303.
When grown as sc tumors in the nude (nu/nu) mouse, cells of the established human renal carcinoma cell line 786-0 produce hypercalcemia; this has an apparent humoral basis because it is reversed by resection of the primary tumor. We have investigated the pathogenesis of hypercalcemia in this model. Tumor-bearing mice were hypercalcemic (13.4 +/- 0.9 vs. 9.52 +/- 0.13 mg/dl in control mice) and hypophosphatemic (10.0 +/- 0.8 vs. 13.8 +/- 1.5 mg/dl in control mice; all values are mean +/- SEM). The serum concentration of 1,25-dihydroxyvitamin D was increased in tumor-bearing animals (70.0 +/- 9.3 vs. 43.8 +/- 4.8 pg/ml in control animals). Urinary excretion of cAMP was similar in control (33.7 +/- 1.4 nmol/mg creatinine) and tumor-bearing mice (38.2 +/- 4.7 nmol/mg creatinine). However, in the latter, the acute response of urinary cAMP to PTH was blunted. Although intestinal calcium transport in everted duodenal sacs in vitro was increased in tumor-bearing mice, hypercalcemia was unaffected by feeding the animals for 8 days a diet containing less than 0.02% calcium. Hence, absorption of dietary calcium did not play a significant role in maintenance of hypercalcemia. In hypercalcemic animals, the calcium content of the humerus was decreased (2.95 +/- 0.08 vs. 3.29 +/- 0.13 mg in controls; P less than 0.05). Quantitative histomorphometric analysis of the distal femoral metaphysis disclosed a significant reduction in trabecular bone volume in tumor-bearing mice (12.0 +/- 1.1% vs. 16.1 +/- 1.1% in controls; P less than 0.02). A strong trend for increased osteoclast surface and number was observed, suggesting that bone resorption was increased. Osteoblast surface and number were also somewhat increased, as was the rate of mineral apposition (2.55 +/- 0.14 vs. 1.91 +/- 0.04 micron/day in controls; P less than 0.01). Thus, the decrease in trabecular bone volume was associated with high turnover of bone, with an apparent net increase in bone resorption. We conclude that hypercalcemia in the nude mouse bearing human renal carcinoma cells is associated with increased bone resorption, high bone turnover, hypophosphatemia, and increased serum levels of 1,25-dihydroxyvitamin D.
将已建立的人肾癌细胞系786 - 0的细胞接种到裸(nu/nu)鼠体内形成皮下肿瘤时,会引发高钙血症;这显然有体液因素,因为切除原发肿瘤后高钙血症会逆转。我们研究了该模型中高钙血症的发病机制。荷瘤小鼠出现高钙血症(13.4±0.9mg/dl,而对照小鼠为9.52±0.13mg/dl)和低磷血症(10.0±0.8mg/dl,对照小鼠为13.8±1.5mg/dl;所有数值均为平均值±标准误)。荷瘤动物血清1,25 - 二羟维生素D浓度升高(70.0±9.3pg/ml,对照动物为43.8±4.8pg/ml)。对照小鼠(33.7±1.4nmol/mg肌酐)和荷瘤小鼠(38.2±4.7nmol/mg肌酐)的尿cAMP排泄量相似。然而,在荷瘤小鼠中,尿cAMP对甲状旁腺激素(PTH)的急性反应减弱。尽管荷瘤小鼠体外外翻十二指肠囊的肠道钙转运增加,但给动物喂食钙含量低于0.02%的饲料8天,高钙血症并未受到影响。因此,膳食钙的吸收在维持高钙血症中未起重要作用。高钙血症动物的肱骨钙含量降低(对照为3.29±0.13mg,高钙血症动物为2.95±0.08mg;P<0.05)。对股骨远端干骺端进行定量组织形态计量学分析发现,荷瘤小鼠的小梁骨体积显著减少(对照为±1.1%,荷瘤小鼠为12.0±1.1%;P<0.02)。观察到破骨细胞表面和数量有增加的强烈趋势,提示骨吸收增加。成骨细胞表面和数量也有所增加,矿物质沉积率也增加(对照为1.91±0.04μm/天,荷瘤小鼠为2.55±0.14μm/天;P<0.01)。因此,小梁骨体积的减少与骨转换率高有关,骨吸收明显净增加。我们得出结论,携带人肾癌细胞的裸鼠出现高钙血症与骨吸收增加、骨转换率高、低磷血症以及血清1,25 - 二羟维生素D水平升高有关。